Calling all movers and shakers in Houston innovation — nominations are now open for The Listies. Photo via Getty Images

The nominations have closed. The original story below has been edited to reflect the extension.

Calling all Houston startups — you're going to want to hear this. Houston Exponential and InnovationMap have teamed up to create an event to honor the best of Houston innovation.

The awards program — dubbed The Listies, a nod to the HTX TechList that launched earlier this year — will take place on Friday, November 20, online as a part of Impact Hub's annual The Houston Innovation Summit (THIS). Click here to register for the event.

The Listies will feature 11 awards — some honoring startups and others focusing on mentors, corporations, and investors. To nominate an MVP in Houston innovation, click the appropriate category and submit a nomination. Note: All nominees will need to have a page on the HTX TechList to be considered for the award. If they do not, they will be contacted to create one. Join the HTX TechList here.

The Listies Categories

Startup awards:

  • Soonicorn: Which company do you think will be Houston's next unicorn ($1 billion and up valuation)?
  • COVID pivot / COVID Phoenix: Which company had the best rebound after the negative effects of the COVID pandemic?
  • Civil Innovation: Which company led the charge in positive transformation for the city of Houston and the greater Houston area?
  • Welcome to Houston: What is the most promising startup that relocated their headquarters to Houston this year?
  • People's Choice Award: Who is your all-around favorite Houston startup company? (Voting will begin after nominations close.)
Individual awards:

Corporate and investing awards:

The winners will be selected by a group of judges representing the Houston innovation ecosystem. The deadline to submit a nomination is November 6.
Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

TMC launches new biotech partnership with Republic of Korea

international collaboration

Houston's Texas Medical Center has launched its new TMC Republic of Korea BioBridge.

The new partnership brings together the TMC with the Osong Medical Innovation Foundation, or KBIOHealth. The Biobridge aims to support the commercialization of Korean biotech and life science startups in the U.S., foster clinical research, and boost collaboration in the public, private and academic sectors.

Through the partnership, TMC will also develop a Global Innovators Launch Pad to foster U.S. market entry for international health care companies. Founders will be selected to participate in the 10-week program at the TMC Innovation Factory in Houston.

“Gene and cell therapies are driving biotech innovation, opening possibilities for treating diseases once thought untreatable," William McKeon, president and CEO of the Texas Medical Center, said in a news release. "Expanding biomanufacturing capacity is essential to delivering the next wave of these therapies, and partnerships with leading innovators will strengthen our efforts in Houston and internationally.”

McKeon officially signed the TMC Korea BioBridge Memorandum of Understanding with Myoung Su Lee, chairman of KBIOHealth, in South Korea in October.

"This collaboration marks a significant milestone for Korea’s biohealth ecosystem, creating a powerful bridge between Osong and Houston," Lee added in the release. "By combining KBIOHealth’s strength in research infrastructure and Korea’s biotech talent with TMC’s global network and accelerator platform, we aim to accelerate innovation and bring transformative solutions to patients worldwide.”

This is the seventh international strategic partnership for the TMC. It launched its first BioBridge with the Health Informatics Society of Australia in 2016. It launched its TMC Japan BioBridge, focused on advancing cancer treatments, last year. It also has BioBridge partnerships with the Netherlands, Ireland, Denmark and the United Kingdom.